Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Technical Indicators

Is This Why The Titan Medical (TMDI) Stock Rose Extended Trading?

January 3, 2023
in Technical Indicators

After-hours trading on Friday saw Titan Medical Inc. (Nasdaq: TMDI) shares rise 10.51% to $0.73 after the medical device maker received approval for a U.S. patent.

Which patent has TMDI been given the green light on?

The United States Patent and Trademark Office (USPTO) recently issued patent No. 11,504,191, titled “Graphical User Interface for a Robotic Surgical System,” according to a recent announcement by Titan Medical (TMDI). The patent, which aims to improve the user experience for surgeons, typically addresses the overlaying of a graphical user interface (GUI) over a surgical workspace to track tool movement.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Titan Medical’s strategic objective to independently develop and safeguard a strong patent portfolio in robotic-assisted surgery (RAS), especially around the Enos robotic single-access surgical system, led to the issuance of this patent. The news confirmed TMDI’s dedication to the robotic-aided surgery innovation continuum. This patent illustrates TMDI’s emphasis on becoming an early mover in single-access RAS along with recent patent application submissions, including those that have just been published.

The technology described in this patent may be used to improve single-access RAS further than the Enos system, including next-generation single-access RAS technologies and systems, as well as early-stage artificial intelligence that works to control the mobility of equipment, including movements based on patient anatomy or more general keep-out zones. TMDI has possibilities for revenue generation and other such strategic opportunities because of the richness and breadth of its patent portfolio.

The technology covered by the awarded patent creates a three-dimensional boundary for surgical tools based on movement produced by a user-controlled hand controller. A two-dimensional projection of the instrument’s position on the surgeon’s screen, based on visual data, before the patient image processing or scans, or other personalized medical data embodying one or more keep-out zones, is also covered by this technology, giving the surgeon user the ability to restrict instrument movement.

How would this boost TMDI’s future growth?

The Enos system’s surgeon workstation, dexterous articulating instruments, patient care, ergonomic hand controllers, advanced control software, instinctive surgeon overlays for providing interoperative feedback, and enhanced vision are just a few of the single-access RAS components that are supported and covered by the extensive intellectual property portfolio Titan Medical (TMDI) has built up. TMDI may have access to a range of intellectual property alternatives through this coverage, including the chance to further safeguard its RAS innovations through licensing and the security of strategic choices.

Tags: NASD: TMDINASDAQ: TMDITitan MedicalTitan Medical IncTitan Medical Inc StockTitan Medical StockTMDI StockTMDI Stock Price

Related Posts

Why Has The Aziyo (AZYO) Stock Price Gained 12% In Pre-Market Session?

December 9, 2022

On What Basis Did Gamida Cell (GMDA) Stock Drop -21% In Pre-Market Trading On Tuesday?

November 22, 2022

Why Is The electroCore (ECOR) Stock Plummeting The Pre-Market Session?

November 4, 2022

Why Is The Milestone Pharmaceuticals (MIST) Stock Rocketing In The Pre-Hours Session?

October 17, 2022

AVCT Stock Dropped 27% In Pre-Market Session: Why?

September 30, 2022

Is This Why The Virios Therapeutics (VIRI) Stock Is Rising Pre-Hours?

September 20, 2022
Next Post

There is little time left for Borr Drilling Limited (BORR) to reach its 1-year target estimate. How soon will it surpass it?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

The shares of Genie Energy Ltd. (GNE) have recorded the market capitalization of 227.64M

3 months ago

Reasons why Valens Semiconductor Ltd.’s (NYSE:VLN) fundamentals are futile

3 months ago

There has been a significant shift in the fundamentals for Vontier Corporation (NYSE:VNT)

1 month ago

Can Achilles Therapeutics plc (ACHL) stock recover despite sales dropping?

1 month ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch